biotechnology

Dr. Heba S. Abbas, Technical Manager of Microbiology at EDA, Egypt. Principal Investigator bridging regulatory science, AI biofilm prediction, and algal nanomedicine architecture. Published 18 papers with Springer/Elsevier. Excited to connect and foster high-impact biotech collaborations!

By: AquaNab With sea lice costing the aquaculture industry an estimated USD 4 billion annually, the Hamburg-based company has developed AquaNabs, a first-of-its-kind nanoantibody treatment, delivered through fish feed, offering a sustainable alternative to conventional chemical and mechanical delousing.  AquaNab, a Hamburg-based biotechnology company, is developing precision nanoan…

Thermophilic bacteria represent a powerful class of extremophiles whose ability to thrive at elevated temperatures makes them indispensable to modern biotechnology. The Arabian Gulf characterized by extreme heat, geothermal systems, hot springs, oil reservoirs, and hypersaline habitats hosts a rich yet understudied reservoir of these organisms. This review consolidates current insights into the d…

From cancer cells to climate-resilient trees: how CRISPR is transforming research at VIB From decoding gene function to tackling cancer and building a sustainable future, VIB researchers are using CRISPR to push the boundaries of life science. A cancer cell escaping therapy. A yeast cell revealing the secrets of gene regulation. A poplar tree engineered without introducing foreign DNA. At first g…

Using digital blueprints of the metabolism of microbes, scientists can simulate expensive and time-intensive experiments set in space, power plants and farm fields.

Colossal Biosciences’ artificial egg technology would deliver a useful tool for the conservation of threatened birds, but only if it’s made publicly available.

Cell cultures are common tools in biology and drug development. Bringing them up to scale to meet the meat needs of societies will require further development.

University of Florida Mechanical and Aerospace Engineering Associate Professor Amor Menezes has been appointed to the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology at the National Academies of Sciences, Engineering, and Medicine (NASEM). The committee brings together experts from academia, industry and government to examine emerging biotechno…

BlueRock says it’s helping advance the cell therapy industry by developing an automated system for analytical auditing. They say it’s among the few systems specifically designed for this application. The post Cell Therapy Company Aims to Pioneer Analytics Automation appeared first on GEN - Genetic Engineering and Biotechnology News .

Anaerobic fermentation (AF) emerged as a promising technology to produce short-chain fatty acids (SCFAs). However, downstream processing of SCFAs is often challenging and costly due to the complexity of AF effluents that present high solids content. Sequencing batch reactors (SBRs) promote effluent separation in two phases (solids and supernatant), which can be an advantage to facilitate SCFAs do…

Scientists have made a breakthrough that may make it possible to create human organs on demand in the future. A team of researchers has achieved what one of its leaders described as feeling "a bit like sci-fi" — using CRISPR gene-editing technology to excise the Y chromosome from male mouse embryos, effectively converting them into females. The resulting animals were female clones genetically ide…

[Nature Biotechnology] Investigators presented a virus-like particle-based toolkit that delivers diverse CRISPR editing modalities to human monocytes, macrophages and dendritic cells with high efficiency while preserving viability and innate immune responsiveness.

In this GEN webinar, experts from Rose BioSolutions, a CDMO and Cell Solutions organization formed from Charles River Laboratories’ businesses, will discuss how integrating regulatory strategy at the earliest stages of development can reduce overall risk and improve program outcomes. The post Embedding Regulatory Strategy in Cell and Gene Therapy Development appeared first on GEN - Genetic Engine…

Lonzas Rapid Media Prototyping gives scientists faster access to custom liquid and powder media for screening process confirmation and early development helping accelerate timelines and prepare for GMP manufacturing

In a recent study researchers developed a visible-light 4D bioprinting platform that self-folds into duct-like, perfusable breast cancer scaffolds and shows how tissue shape, stiffness and flow-like cues influence triple-negative breast cancer cell behavior and drug response.

Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies. The post Eight biotech companies in Melbourne you should know about appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is …

Exobiosphere, the space biotechnology company advancing drug discovery and biomedical research in microgravity, has secured €1 million in non-dilutive funding through Luxembourg's Jeune Entreprise Innovante (JEI) aid, administered by the Ministry of the Economy . The funding will accelerate the comp...

Carolina Villa spent a decade scaling bioprocesses in industry: first at DSM, the Dutch multinational known for its fermentation and biotechnology work, then at CJ CheilJedang, a South Korean food and biotechnology company and one of the world's largest producers of fermentation-based bioproducts. She has since moved to the investor side, where she's now a Principal at Nucleus Capital, suppo…

Dr. Jessica Dymond, Ph.D. — Vice President of Technology, In-Q-Tel. The same technologies that could transform medicine, agriculture, and manufacturing could also reshape global security. Understanding the future of biotechnology requires scientists who can bridge discovery, engineering, and responsibility. Today on Progress, Potential, and Possibilities, we’re joined by a true pioneer at the nex…